First-line combined therapy improves metastatic non-small cell lung cancer survival regardless of mutational status. . Cancer 2022;128:4039.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. First-line combined therapy improves metastatic non-small cell lung cancer survival regardless of mutational status. Cancer 2022;128:4039.
PMID: 36382892